fda glp-1 warning letters news Issues Against Online Sellers Beyond the Headlines: FDA Warning

Activation of the GLP-1 receptor by a non-peptidic agonist

Companies like Nestl Health Science, Abbott, and Herbalife are developing nutrient-dense formulations focused on protein, B12, electrolytes, and appetite support, often bundled with telehealth or pharmacy programs

Mounjaro is FDA-approved to: Control blood sugar levels in adults and children ages 10+ with type 2 diabetes mellitus Zepbound is FDA-approved to: Reduce excess body weight and manage weight long term in adults with obesity or overweight who have at least one weight-related health condition (e.g

Pfizer scrapped a different once-daily obesity pill back in June 2023 after patients who took that drug had higher liver enzyme levels in a mid-stage trial

Monthly injections bypass the absorption challenge entirely and ensure consistent B12 levels